Differential display screening for specific gene expression induced by dietary nonsteroidal estrogen

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Daidzein is a dietary phytoestrogen with known biological activities.
• Estrogen-responsive human breast carcinoma MCF-7 cells are a standard model for studying breast cancer.
• Phytoestrogens can exhibit complex interactions with cellular processes.

Purpose of the Study:

• To investigate the effect of daidzein on the proliferation of estrogen-responsive human breast carcinoma MCF-7 cells.
• To identify genes regulated by daidzein in these cells.
• To characterize the cellular and molecular responses to daidzein exposure.

Main Methods:

• Cell proliferation assays were performed using cultured MCF-7 cells.
• Daidzein was administered at various concentrations.
• Cell morphology and volume were assessed.
• Differential display reverse transcriptase polymerase chain reaction (DD-RT-PCR) was employed to identify differentially expressed genes.
• Sequence homology analysis was conducted on identified cDNA fragments.

Main Results:

• Daidzein demonstrated a biphasic effect on MCF-7 cell proliferation: stimulation at 0.25 microg/ml and significant inhibition at concentrations >25 microg/ml (IC50 = 50 microg/ml).
• High-dose daidzein (50 microg/ml) induced alterations in cell morphology, decreased cell volume, and caused chromosome condensation.
• DD-RT-PCR identified several daidzein-regulated genes, including one with high homology to a fetal human brain expressed sequence tag (EST 06411).

Conclusions:

• Daidzein exhibits dose-dependent effects on breast cancer cell proliferation, with inhibitory effects at higher concentrations.
• Daidzein exposure leads to significant morphological and potential genotoxic changes in MCF-7 cells.
• The study identified novel genes, including EST 06411, whose expression is modulated by daidzein, suggesting complex regulatory pathways.